NCT03187990View on ClinicalTrials.gov

Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA

NACompletedINTERVENTIONAL
Enrollment

52

Participants

Timeline

Start Date

March 3, 2017

Primary Completion Date

August 3, 2021

Study Completion Date

August 3, 2021

Conditions
Prostate Cancer
Interventions
DRUG

[68Ga]PSMA-11

PET/MRI with \[68Ga\]PSMA will be compared to mpMRI for biopsy guidance.

DRUG

[18F]PSMA-1007

18F-PSMA-1007 PET/CT for biopsy guidance and intraoperative target verification.

Trial Locations (1)

8091

University Hospital Zurich, Zurich

All Listed Sponsors
lead

Irene Burger

OTHER

NCT03187990 - Positron Emission Tomography / Magnetic Resonance Imaging (PET/MRI) Guided Biopsy in Men With Elevated PSA | Biotech Hunter | Biotech Hunter